Category: 2024
Granules India achieves SBTi approval for ambitious net-zero goals
Granules India Gets US FDA Nod For Tablets To Treat Major Depressive Disorder
Granules India Launches ‘Breast Health Express’ Mobile Unit For Cancer Screening
Granules India gets USFDA nod for generic Glycopyrrolate oral solution
USFDA gives nod to Granules India’s generic formulation to treat depression
Empowering Women, Driving Change: Priyanka Chigurupati On Leadership And Inclusivity In The Health Industry
Granules India announces ANDA approval for Colchicine Capsules, drug has annual US sales of $55 million
Granules API, formulations facility in Vizag completes U.S. FDA inspection






































